key: cord-0745453-l3mxy0iv authors: Gatto, Antonio; Pulitano, Silvia; Conti, Giorgio; Soave, Paolo Maurizio; Di Sarno, Lorenzo; Chiaretti, Antonio title: Botulism during SARS-CoV-2 pandemic: the importance of differential diagnoses date: 2021-05-26 journal: Anaerobe DOI: 10.1016/j.anaerobe.2021.102389 sha: 9d878d4559071d5766faaf5ba4d3bfe6ea9f6397 doc_id: 745453 cord_uid: l3mxy0iv Botulism is a neuroparalytic syndrome caused by a neurotoxin produced by Clostridium botulinum. We describe a patient with neurological symptoms associated with intoxication by Clostridium botulinum and infection by SARSCoV2. This report underlines that it is mandatory, even in case of SARS-CoV-2 positivity, to investigate all the causes of a clinical pattern. Botulism is a neuroparalytic syndrome caused by a neurotoxin produced by the bacterium 45 Clostridium botulinum and rarely by Clostridium butyricum or Clostridium barati. Clostridium 46 botulinum is a gram-positive, spore-forming, rod-shaped, anaerobic bacterium. It is generally classified into 8 serotypes (from A to H) according to the antigenicity of the toxin. Only some type Focusing on her eyes, the patient showed a mydriatic pattern. Furthermore, the pupillary light reflex 71 was unresponsive. She referred general fatigue, progressive dysphagia, difficulty with mastication, 72 eye and face muscle movement. She reported last evacuation 10 days earlier. The patient's mother was conducted to our adult department of emergency with similar signs and 74 symptoms while her father was in good clinical condition. 75 We interviewed the patient and her father to find out more data about her medical history and the 76 meals she had eaten in the last few days, especially homemade food. 77 We found that ten days earlier, they had eaten home-made tuna in oil and her father reported to 78 have eaten a smaller amount. The following night they had gastrointestinal symptoms such as 79 abdominal pain and vomiting. The routine blood tests were negative. An antigenic swab test for SARS-CoV-2 was performed, The Guillaime-Barrè syndrome should also be considered, the clinical features are the main way to 144 make a differential diagnosis, it is characterized by ascending paralysis, sensory deficits and high manifestations were a further option for the differential diagnosis. Our patient was afebrile in the whole period, and she did not have cough, sore throat, headache, loss 153 of taste or smell or nose congestion. She reported general fatigue and blurred vision, she had one 154 episode of vomiting following the ingestion of the homemade tuna and, most of all, she had a 155 severe conjunctival hyperemia. All these items made the COVID-19 differential diagnosis more 156 likely so we had to consider the nervous system involvement of SARS-CoV-2 infection with some Neurological symptoms, manifestations, and complications associated 194 with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 195 (COVID-19) The neurological manifestations of COVID-19: a 197 review article COVID-19 presenting with ophthalmoparesis from 200 cranial nerve palsy Botulism in Italy Foodborne botulism treated with heptavalent botulism 205 antitoxin Botulism, where are we now? Clin Toxicol (Phila) Diagnosis and treatment of botulism: a century later, clinical suspicion remains the 216 cornerstone Transient cortical blindness in COVID-19 222 pneumonia; a PRES-like syndrome: Case report COVID-19): A Systematic Review and Meta-Analysis, Front Neurol Bickerstaff encephalitis after COVID-19 COVID-19 diagnosis and management: a comprehensive review Neurological manifestations of COVID-235 19: A brief review Update on neurological manifestations of COVID-238 19